This article is for informational purposes only and does not constitute medical advice. Clinical trial eligibility and availability vary. Always consult a qualified healthcare professional before making any medical decisions or considering participation in a clinical trial.
Summary
Clinical trials offer access to treatments not yet widely available, careful medical monitoring, and the opportunity to contribute to medical knowledge that benefits future patients. Yet many people who could benefit from trials never enroll — often because the process of finding and joining a trial feels opaque and complicated. This 2026 patient guide walks through every step: searching effectively, understanding eligibility criteria, navigating the screening process, signing informed consent, and knowing your rights and responsibilities as a participant.
Step 1: Clarify What You're Looking For
Before searching, be clear about your situation and goals. Clinical trials serve different purposes at different stages of disease: prevention trials (for people at risk but not yet ill), treatment trials (for people with a diagnosed condition), supportive care trials (for managing symptoms or side effects), and screening/diagnostic trials (testing better ways to detect disease). Your current treatment status matters — many trials require that you have tried and failed specific prior therapies, while others (especially prevention and early-stage disease trials) require that you have not had certain treatments.
Gather your medical records before starting your search: diagnosis with stage/subtype if applicable, dates of prior treatments and responses, current medications, recent lab results (complete blood count, metabolic panel, organ function markers), recent imaging reports, and any known genetic mutations (for cancer, this means your tumor's molecular profile). The more organized your medical information, the faster you can evaluate your eligibility for specific trials. A clinical trial coordinator will ask for all of this during screening.
Step 2: Search ClinicalTrials.gov Effectively
ClinicalTrials.gov is the official US registry of all clinical trials, maintained by the National Library of Medicine. Every trial testing a drug or device in humans in the US must be registered here (under the FDAAA 2007 requirement). Searching effectively requires knowing which filters to use: search by "Condition or disease" (enter your specific diagnosis — "breast cancer" is better than "cancer"), filter "Recruitment Status" to "Recruiting" (studies actively enrolling), specify your location and a search radius, and filter "Phase" if you have a preference. The "Study type" filter (interventional vs. observational) distinguishes treatment trials from registry/natural history studies.
The results page shows each trial's title, sponsor, phase, study type, and brief description. Clicking through to a trial's full record reveals: the "Eligibility" section (inclusion and exclusion criteria), the "Contacts and Locations" section (where to call or email to express interest), and the "Description" section with scientific background. The eligibility criteria can be dense with medical jargon — if you find a potentially relevant trial but can't parse the eligibility language, call the contact number and ask the trial coordinator to help you determine if you might qualify. That's exactly what they're there for.
Step 3: Use Additional Search Resources
ClinicalTrials.gov is comprehensive but has a technical interface that can be challenging. Several supplementary resources offer more patient-friendly search experiences: the NCI's cancer.gov/research/participate trial finder (for cancer trials, with consultation support at 1-800-4-CANCER), ResearchMatch.org (a national registry matching patients with studies by condition and demographics), Antidote (antidote.me, AI-powered trial matching), TrialSpark, and Trovagene. For disease-specific searches, the relevant advocacy organization almost always maintains a curated trial database — the Alzheimer's Association TrialMatch, American Diabetes Association trial finder, ClinicalTrials.gov for Rare Diseases, and dozens of condition-specific equivalents.
Your treating physician is also a critical resource — doctors often know of trials at their institution or affiliated centers before they appear widely in databases. Telling your doctor explicitly "I am interested in clinical trial participation" can open doors to trials not yet fully enrolled or listed. Academic medical centers' trial matching programs (offered at most NCI-designated Cancer Centers) can match your profile against the full portfolio of trials at that institution.
Step 4: Understand Eligibility Criteria Before Contacting
Every clinical trial has inclusion criteria (requirements you must meet to enroll) and exclusion criteria (factors that disqualify you). Reading eligibility criteria carefully before contacting can save time for both you and the trial site. Common inclusion criteria types: age range, specific diagnosis with confirmed subtype or stage, prior treatment history (e.g., "must have received at least 1 prior chemotherapy regimen"), performance status (ECOG 0–2 or Karnofsky 60–100), adequate organ function (specific lab thresholds for kidney, liver, bone marrow function), and biomarker requirements (e.g., EGFR mutation positive, HER2 3+ by IHC).
Common exclusion criteria types: active serious infection, prior treatment with the same drug class as the experimental agent, recent surgery within a defined washout period, active autoimmune disease (for immunotherapy trials), current anticoagulation use (for trials with bleeding risk), pregnancy or breastfeeding, and "brain metastases" exclusions (though many trials now allow stable, treated brain mets). If you meet all visible inclusion criteria and none of the visible exclusion criteria, contact the trial — there will always be additional screening to confirm eligibility.
Step 5: Contact the Trial Site and Navigate Screening
The "Contacts and Locations" section of a ClinicalTrials.gov record lists a central contact (often a research coordinator or principal investigator's office) and site-specific contacts at each enrolling location. A brief initial inquiry email or phone call describing your diagnosis, current treatment status, and interest in the trial is the best first contact. The trial coordinator will typically ask you to send medical records for pre-screening — a quick review to flag obvious ineligibility issues before scheduling a formal screening visit. If you pass pre-screening, a formal screening visit at the trial site involves physical examination, additional laboratory tests (sometimes including specialized biomarker tests not available in standard care), and possibly imaging or biopsies specific to trial requirements.
Screening can take 2–6 weeks depending on the trial requirements and your baseline test results. During this period, you are not yet enrolled and receive no experimental treatment. If screening results confirm eligibility, you will be invited to enroll. If you are screen failed (a screening result disqualifies you), the coordinator will explain the reason — this is not a rejection of you personally but a reflection of trial requirements. Many patients who are screen failed for one trial are eligible for others with different criteria.
Step 6: Informed Consent — Your Rights and What to Ask
Informed consent is a cornerstone of ethical clinical research. You must sign an informed consent form (ICF) before any trial-specific procedures begin (including screening tests in most cases). The ICF must cover: the purpose of the study, what procedures you will undergo, the known risks and benefits, alternative treatments available outside the trial, confidentiality protections, compensation for injury if applicable, and your unconditional right to withdraw at any time without penalty. Federal regulations require that consent be given in language you can understand — you can request a plain language version, ask for an interpreter, and take as much time as you need before signing.
Ten questions every patient should ask before signing: (1) What is the purpose of this trial? (2) What are all the tests and procedures I will undergo? (3) Which arm might I be randomized to, and what are the odds? (4) What are the most common and most serious side effects? (5) Are there alternative treatments I should know about? (6) Will my regular doctor receive information about my participation? (7) What happens if I am injured as a result of the trial? (8) Who do I contact if I experience side effects between visits? (9) Can I continue if I move or if the trial site closes? (10) Will I receive the experimental treatment after the trial ends if it works?
Step 7: Participating — What to Expect Day to Day
Once enrolled, your schedule depends on the trial design. Phase 1 trials typically require frequent early visits (weekly or biweekly at first) that taper as safety is established. Phase 3 trials may have visit schedules very similar to standard care, with additional visits for study assessments at specific time points. You will receive a trial calendar, a 24-hour emergency contact number, and clear instructions on what to report between visits (symptoms, new medications, hospitalizations). Keeping a symptom diary and bringing it to each visit helps the research team document your experience accurately.
You will be asked about concomitant medications at every visit — some drugs can interact with experimental agents or interfere with the study. Do not start any new medication (including supplements and over-the-counter products) without informing the trial team first. You may withdraw from the trial at any time — this will not affect your access to standard care and will not change your relationship with your treating physician. If the trial ends early (due to safety signals, regulatory decisions, or sponsor decisions), the trial site will inform you and help you transition to appropriate care.
Key Takeaways
- Gather organized medical records (diagnosis, prior treatments, recent labs, imaging reports, molecular/genetic testing results) before starting your search — this accelerates every step from eligibility assessment to screening.
- ClinicalTrials.gov is comprehensive; supplementary patient-friendly tools (NCI cancer.gov finder, ResearchMatch, Antidote) and disease-specific advocacy organization trial finders are valuable complements.
- Telling your treating physician you are interested in trial participation often surfaces opportunities not visible in public databases — academic centers' internal trial matching programs access the full local portfolio.
- Being screen failed for one trial is not a setback — it simply reflects that trial's specific requirements. Many patients are eligible for different trials with different criteria, and trial coordinators can often point you to alternatives.
- Informed consent is a process, not a signature — you have the right to ask every question you need answered, request plain language, take time to decide, and withdraw at any point without affecting your standard care access.